drugset / Trial / NCT01344902

An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon

NCT01344902

Phase 1/2 Terminated 13 enrolled Photocure
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of the study is to determine if it is possible to detect more pre-cancerous lesions in colon when using fluorescence technology.

Timeline

Start
2009-02
Primary completion
2009-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject hexaminolevulinate Small molecule 200 mg Oral

Indications